DOCSLIB.ORG

Coffea Arabica Bean Extract Inhibits Glucose Transport and Disaccharidase Activity in Caco‑2 Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Coffea Arabica Bean Extract Inhibits Glucose Transport and Disaccharidase Activity in Caco‑2 Cells BIOMEDICAL REPORTS 15: 73, 2021 Coffea arabica bean extract inhibits glucose transport and disaccharidase activity in Caco‑2 cells ATCHARAPORN ONTAWONG1, ACHARAPORN DUANGJAI1 and CHUTIMA SRIMAROENG2 1Division of Physiology, School of Medical Sciences, University of Phayao, Muang Phayao, Phayao 56000; 2Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Nong Khai 52000, Thailand Received February 3, 2021; Accepted June 14, 2021 DOI: 10.3892/br.2021.1449 Abstract. The major constituents of Coffea arabica (coffee), or sucrase‑isomaltase cleaves the α‑glucoside bonds of including caffeine, chlorogenic acid and caffeic acid, exhibit disaccharides, including sucrose, to monosaccharides. The antihyperglycemic properties in in vitro and in vivo models. absorption of dietary monosaccharides by the intestine may However, whether Coffea arabica bean extract (CBE) regu‑ be one of the risk factors associated with diabetes mellitus (1). lates glucose uptake activity and the underlying mechanisms Glucose derived from starch or sucrose is taken up by the involved remain unclear. The aim of the present study was epithelial cells through the brush border membrane (BBM), to examine the effects of CBE on glucose absorption and predominantly by a sodium‑dependent glucose co‑transporter identify the mechanisms involved using an in vitro model. (SGLT1) (2,3). A previous study has revealed that glucose The uptake of a fluorescent glucose analog into Caco‑2 transporter 2 (GLUT2) is expressed at the BBM of enterocytes colorectal adenocarcinoma cells was determined. The expres‑ during the digestive phase and may affect circulatory glucose sion levels of sodium glucose co‑transporter 1 (SGLT1) and concentration (2). Subsequently, glucose effluxes across the baso‑ glucose transporter 2 (GLUT2) were evaluated. In addition, lateral membrane (BLM) to the blood circulation via GLUT2. glycoside hydrolase enzyme activity was investigated. It Therefore, any factor that influences the activity of SGLT1 and was observed that CBE inhibited disaccharidase enzyme GLUT2 also alters the absorption and metabolism of glucose. activity. Furthermore, CBE exerted an inhibitory effect on Previous studies have reported that intestinal SGLT1 mRNA intestinal glucose absorption by downregulating SGLT1‑ and expression is increased in streptozotocin‑induced diabetic rats GLUT2‑mediated 5' AMP‑activated protein kinase phosphory‑ and mice (4,5). Additionally, Otsuka Long‑Evans Tokushima lation and suppressing hepatocyte nuclear factor 1α expression. Fatty rats exhibiting increased intestinal SGLT1 mRNA expres‑ These data suggest that CBE may attenuate glucose absorption sion combined with impaired glucose tolerance ultimately and may have potentially beneficial antihyperglycemic effects developed insulin resistance and hyperinsulinemia (6). Similarly, in the body; however, the mechanisms underlying the effects patients with type 2 diabetes mellitus also exhibit elevated intes‑ of CBE must be elucidated through further investigation. tinal glucose uptake as a result of increased SGLT1 mRNA and protein expression (7). Furthermore, GLUT2 protein expression Introduction is increased at the BBM of enterocytes in streptozotocin‑induced diabetic rats (8) and in response to elevated glucose levels in the Type 2 diabetes is a disease that occurs when blood glucose levels intestinal lumen (9). Therefore, intestinal SGLT1 and GLUT2 are high, which is referred to as hyperglycemia. The severity of have a significant impact on the progression of diabetes mellitus. hyperglycemia is determined by an imbalance between glucose Coffea arabica is one of the most widely consumed bever‑ entering and leaving the circulation. Carbohydrates from the ages. In traditional Chinese medicine, the green Coffea bean diet are hydrolyzed by digestive enzymes. α‑Glucosidase is classified as a blood circulation warmer, liver qi (Chinese concept of energy) and menstrual regulation, stimulant, heart orifice opening, detoxification and tonification herb (a traditional Chinese medicine therapeutic concept that nourishes and replen‑ ishes the qi and blood of weakened individuals) (10). At present, Correspondence to: Dr Atcharaporn Ontawong, Division of Physiology, School of Medical Sciences, University of Phayao, the Coffea species C. arabica (Arabica) and C. canephora 19 Moo 2 Mae‑Ka, Muang Phayao, Phayao 56000, Thailand (Robusta) are economically important in the global coffee market. E‑mail: [email protected] The major constituents of Coffea include caffeine, chlorogenic acid, diterpenes and trigonelline (11). Moderate intake of Coffea Abbreviations: CBE, Coffea arabica bean extract; GLUT2, has been linked to a reduced risk of chronic diseases, including glucose transporter 2; SGLT1, sodium glucose co‑transporter 1 type 2 diabetes, Parkinson's disease and liver disease (12‑14). As mentioned above, there are several studies on the antidiabetic Key words: CBE, 5' AMP‑activated protein kinase, glucose uptake, potential of roast Coffea. However, to the best of our knowledge, GLUT2, hepatocyte nuclear factor 1α, SGLT1 the effects of Coffea arabica bean extract (CBE) on glucose absorption and the related mechanisms remain unknown. The 2 ONTAWONG et al: COFFEE BEAN EXTRACT INHIBITS GLUCOSE TRANSPORT aim of the present study was to examine the effects of CBE on Glucose transport in human intestinal Caco‑2 cells. glucose absorption in human Caco‑2 colorectal adenocarcinoma Differentiated Caco‑2 cells were washed three times with PBS cells. Additionally, the molecular mechanisms involved in (pH 7.4) and incubated with 2 mM 2‑NBDG in the presence glucose transport in an in vitro model were determined. or absence of 0.1‑1,000 µg/ml CBE, a molar ratio of four major active compounds of chlorogenic acid (29.62 µg/ml), caffeine Materials and methods (5.11 µg/ml), caffeic acid (3.16 µg/ml), ferulic acid (1.54 µg/ml), phlorizin (0.5 mM) and phloretin (1 mM) for 4 h. The medium Chemicals. DMEM/F12, CelLytic MT mammalian tissue was removed and the cells were washed three times with ice‑cold lysis/extraction reagents, phloretin, chlorogenic acid, PBS. The fluorescence intensity was measured using a Synergy™ caffeine, caffeic acid and ferulic acid were purchased from HT microplate reader (BioTek Instruments, Inc.) at excitation Sigma‑Aldrich; Merck KGaA. FBS was purchased from Gibco; and emission wavelengths of 485 and 535 nm, respectively. Thermo Fisher Scientific, Inc. Polyclonal rabbit anti‑SGLT1 (1:250; cat. no. 07‑1417), GLUT2 (1:250; cat. no. 07‑1402‑I), Determination of cell viability. The viability of Caco‑2 cells 5' AMP‑activated protein kinase (AMPK; 1:250; cat. no. 07‑1417) after exposure to CBE and other test compounds was determined and phospho‑AMPK (1:250; cat. no. 07‑363) were purchased using an MTT assay. Caco‑2 cells were seeded at a density of from Merck KGaA. Monoclonal mouse alkaline phosphatase 5x104 cells/well in 96‑well plates and cultured for 18‑21 days (ALP; 1:500; cat. no. NB110‑3638) antibodies were obtained at 37˚C. On the day of the experiment, culture medium with from Novus Biologicals, LLC. Monoclonal mouse anti‑β‑actin or without test compounds was added and the cells were incu‑ (1:500; cat. no. ab8224) was purchased from Abcam. bated for 4 h at 37˚C. After exposure, the cells were washed 2‑(N‑(7‑nitrobenz‑2‑oxa‑1,3‑diazol‑4‑yl)amino)‑2‑deoxyglucose with PBS, culture medium containing MTT reagent was added (2‑NBDG) was obtained from Thermo Fisher Scientific, Inc. and the cells were incubated for the next 4 h at 37˚C. At the Phlorizin was purchased from Tocris Bioscience. All other chem‑ end of the experiment, the MTT solution was aspirated and the icals with high purity were obtained from commercial sources. cells were washed once with ice‑cold PBS. DMSO was added to each well, and cells were incubated for a further 30 min at CBE extract preparation, purification and qualification. Coffea 37˚C. The absorbance of dissolved formazan was measured at arabica beans were kindly provided by Hillkoff, and a voucher a wavelength of 570 nm using an M965 AccuReader microplate specimen (no. NU003806) was deposited at the herbarium reader (Metertech, Inc.). The sample detected at a wavelength of the Faculty of Biology, Naresuan University, Phitsanulok, of 680 nm was also used as a reference. Thailand. Dried Coffea arabica beans were weighed and blended thoroughly, followed by 100˚C water infusion for Inhibition of disaccharidase activity in Caco‑2 cells. The dose 30 min. Subsequently, the liquid extract was filtered through of CBE used in this experiment was inferred from the glucose filter paper (Whatman plc; GE Healthcare Life Sciences) transport experiment, which revealed that CBE at a dose of three times. The filtrate was evaporated using a lyophilizer 100 µg/ml reduced glucose transport to a similar extent to (Labconco). The chemical constituents of CBE, caffeine, that observed with CBE at a dose of 1,000 µg/ml. Therefore, chlorogenic acid, caffeic acid and ferulic acid (Sigma‑Aldrich; CBE at a dose of 100 µg/ml was selected for further experi‑ Merck KGaA), were used as references for validation and ments. Inhibition of sucrase enzyme activity was determined quantitation by high‑performance liquid chromatography as previously described, with some modifications (17). Briefly, (HPLC) with diode array detection on an Agilent 1200 series differentiated Caco‑2 cells were rinsed three times with Hank's chromatograph (LabX) at the Science and Technology Service balanced salt solution (HBSS) (Sigma‑Aldrich; Merck KGaA). Centre, Faculty of Science, Chiang Mai University (Chiang The cells were subsequently incubated with HBSS containing Mai, Thailand) according to the ISO/IEC 17025 method 28 mM sucrose, which is an α‑glucosidase substrate, in the pres‑ (International Organization for Standardization, 2005) (15). ence or absence of 100 µg/ml CBE, a molar ratio of four major The flow rate was 0.5 ml/min. The mobile phase was a binary active compounds of CBE at 100 µg/ml of chlorogenic acid solvent system consisting of 2% acetic acid dissolved in HPLC (29.62 µg/ml), caffeine (5.11 µg/ml), caffeic acid (3.16 µg/ml), water (solvent A) and absolute methanol (solvent B).
Load more

Recommended publications
  • Natural Products As Lead Compounds for Sodium Glucose Cotransporter (SGLT) Inhibitors
    Reviews Natural Products as Lead Compounds for Sodium Glucose Cotransporter (SGLT) Inhibitors Author ABSTRACT Wolfgang Blaschek Glucose homeostasis is maintained by antagonistic hormones such as insulin and glucagon as well as by regulation of glu- Affiliation cose absorption, gluconeogenesis, biosynthesis and mobiliza- Formerly: Institute of Pharmacy, Department of Pharmaceu- tion of glycogen, glucose consumption in all tissues and glo- tical Biology, Christian-Albrechts-University of Kiel, Kiel, merular filtration, and reabsorption of glucose in the kidneys. Germany Glucose enters or leaves cells mainly with the help of two membrane integrated transporters belonging either to the Key words family of facilitative glucose transporters (GLUTs) or to the Malus domestica, Rosaceae, Phlorizin, flavonoids, family of sodium glucose cotransporters (SGLTs). The intesti- ‑ SGLT inhibitors, gliflozins, diabetes nal glucose absorption by endothelial cells is managed by SGLT1, the transfer from them to the blood by GLUT2. In the received February 9, 2017 kidney SGLT2 and SGLT1 are responsible for reabsorption of revised March 3, 2017 filtered glucose from the primary urine, and GLUT2 and accepted March 6, 2017 GLUT1 enable the transport of glucose from epithelial cells Bibliography back into the blood stream. DOI http://dx.doi.org/10.1055/s-0043-106050 The flavonoid phlorizin was isolated from the bark of apple Published online April 10, 2017 | Planta Med 2017; 83: 985– trees and shown to cause glucosuria. Phlorizin is an inhibitor 993 © Georg Thieme Verlag KG Stuttgart · New York | of SGLT1 and SGLT2. With phlorizin as lead compound, specif- ISSN 0032‑0943 ic inhibitors of SGLT2 were developed in the last decade and some of them have been approved for treatment mainly of Correspondence type 2 diabetes.
    [Show full text]
  • Disaccharidase Deficiencies
    J Clin Pathol: first published as 10.1136/jcp.s3-5.1.22 on 1 January 1971. Downloaded from J. clin. Path., 24, Suppl. (Roy. Coll. Path.), 5, 22-28 Disaccharidase deficiencies G. NEALE From the Department ofMedicine, Royal Postgraduate Medical School, Du Cane Road, London Up to 12 years ago the absorption of disaccharides capable of hydrolysing maltose, which may explain was a problem in physiology which attracted little why maltase deficiency is not found as an isolated attention and which appeared to be unrelated to the defect of the enterocyte. Isomaltase and sucrase problems of clinical medicine. Indeed, most text- appear to be distinct but linked entities, and hence books stated incorrectly that the disaccharides were they are absent together in the hereditary condition hydrolysed to monosaccharides in the lumen of the of sucrase-isomaltase deficiency (Dahlquist and small intestine despite the evidence of half a century Telenius, 1969). Lactase activity consists of at least before, which had suggested that they were digested two separate enzymes, one of which is not in the by the mucosal surface (Reid, 1901). The renewal of brush border but within the cell (Zoppi, Hadom, interest in the subject of disaccharide absorption Gitzelmann, Kistler, and Prader, 1966). The signifi- occurred after the description of congenital lactase cance of intracellular lactase activity is uncertain. It deficiency by Holzel, Schwarz, and Sutcliffe (1959) cannot play any part in the normal digestion of and of sucrase-isomaltase deficiency by Weijers, lactose which is a function of the brush border of the van de Kamer, Mossel, and Dicke (1960).
    [Show full text]
  • Myricetin Antagonizes Semen-Derived Enhancer of Viral Infection (SEVI
    Ren et al. Retrovirology (2018) 15:49 https://doi.org/10.1186/s12977-018-0432-3 Retrovirology RESEARCH Open Access Myricetin antagonizes semen‑derived enhancer of viral infection (SEVI) formation and infuences its infection‑enhancing activity Ruxia Ren1,2†, Shuwen Yin1†, Baolong Lai2, Lingzhen Ma1, Jiayong Wen1, Xuanxuan Zhang1, Fangyuan Lai1, Shuwen Liu1* and Lin Li1* Abstract Background: Semen is a critical vector for human immunodefciency virus (HIV) sexual transmission and harbors seminal amyloid fbrils that can markedly enhance HIV infection. Semen-derived enhancer of viral infection (SEVI) is one of the best-characterized seminal amyloid fbrils. Due to their highly cationic properties, SEVI fbrils can capture HIV virions, increase viral attachment to target cells, and augment viral fusion. Some studies have reported that myri- cetin antagonizes amyloid β-protein (Aβ) formation; myricetin also displays strong anti-HIV activity in vitro. Results: Here, we report that myricetin inhibits the formation of SEVI fbrils by binding to the amyloidogenic region of the SEVI precursor peptide (PAP248–286) and disrupting PAP248–286 oligomerization. In addition, myricetin was found to remodel preformed SEVI fbrils and to infuence the activity of SEVI in promoting HIV-1 infection. Moreover, myricetin showed synergistic efects against HIV-1 infection in combination with other antiretroviral drugs in semen. Conclusions: Incorporation of myricetin into a combination bifunctional microbicide with both anti-SEVI and anti- HIV activities is a highly promising approach to preventing sexual transmission of HIV. Keywords: HIV, Myricetin, Amyloid fbrils, SEVI, Synergistic antiviral efects Background in vivo because they facilitate virus attachment and inter- Since the frst cases of acquired immune defciency nalization into cells [4].
    [Show full text]
  • Activation and Detoxification of Cassava Cyanogenic Glucosides by the Whitefly Bemisia Tabaci
    www.nature.com/scientificreports OPEN Activation and detoxifcation of cassava cyanogenic glucosides by the whitefy Bemisia tabaci Michael L. A. E. Easson 1, Osnat Malka 2*, Christian Paetz1, Anna Hojná1, Michael Reichelt1, Beate Stein3, Sharon van Brunschot4,5, Ester Feldmesser6, Lahcen Campbell7, John Colvin4, Stephan Winter3, Shai Morin2, Jonathan Gershenzon1 & Daniel G. Vassão 1* Two-component plant defenses such as cyanogenic glucosides are produced by many plant species, but phloem-feeding herbivores have long been thought not to activate these defenses due to their mode of feeding, which causes only minimal tissue damage. Here, however, we report that cyanogenic glycoside defenses from cassava (Manihot esculenta), a major staple crop in Africa, are activated during feeding by a pest insect, the whitefy Bemisia tabaci, and the resulting hydrogen cyanide is detoxifed by conversion to beta-cyanoalanine. Additionally, B. tabaci was found to utilize two metabolic mechanisms to detoxify cyanogenic glucosides by conversion to non-activatable derivatives. First, the cyanogenic glycoside linamarin was glucosylated 1–4 times in succession in a reaction catalyzed by two B. tabaci glycoside hydrolase family 13 enzymes in vitro utilizing sucrose as a co-substrate. Second, both linamarin and the glucosylated linamarin derivatives were phosphorylated. Both phosphorylation and glucosidation of linamarin render this plant pro-toxin inert to the activating plant enzyme linamarase, and thus these metabolic transformations can be considered pre-emptive detoxifcation strategies to avoid cyanogenesis. Many plants produce two-component chemical defenses as protection against attacks from herbivores and patho- gens. In these plants, protoxins that are ofen chemically protected by a glucose residue are activated by an enzyme such as a glycoside hydrolase yielding an unstable aglycone that is toxic or rearranges to form toxic products1.
    [Show full text]
  • Defective Galactose Oxidation in a Patient with Glycogen Storage Disease and Fanconi Syndrome
    Pediatr. Res. 17: 157-161 (1983) Defective Galactose Oxidation in a Patient with Glycogen Storage Disease and Fanconi Syndrome M. BRIVET,"" N. MOATTI, A. CORRIAT, A. LEMONNIER, AND M. ODIEVRE Laboratoire Central de Biochimie du Centre Hospitalier de Bichre, 94270 Kremlin-Bicetre, France [M. B., A. C.]; Faculte des Sciences Pharmaceutiques et Biologiques de I'Universite Paris-Sud, 92290 Chatenay-Malabry, France [N. M., A. L.]; and Faculte de Midecine de I'Universiti Paris-Sud et Unite de Recherches d'Hepatologie Infantile, INSERM U 56, 94270 Kremlin-Bicetre. France [M. 0.1 Summary The patient's diet was supplemented with 25-OH-cholecalci- ferol, phosphorus, calcium, and bicarbonate. With this treatment, Carbohydrate metabolism was studied in a child with atypical the serum phosphate concentration increased, but remained be- glycogen storage disease and Fanconi syndrome. Massive gluco- tween 0.8 and 1.0 mmole/liter, whereas the plasma carbon dioxide suria, partial resistance to glucagon and abnormal responses to level returned to normal (18-22 mmole/liter). Rickets was only carbohydrate loads, mainly in the form of major impairment of partially controlled. galactose utilization were found, as reported in previous cases. Increased blood lactate to pyruvate ratios, observed in a few cases of idiopathic Fanconi syndrome, were not present. [l-14ClGalac- METHODS tose oxidation was normal in erythrocytes, but reduced in fresh All studies of the patient and of the subjects who served as minced liver tissue, despite normal activities of hepatic galactoki- controls were undertaken after obtaining parental or personal nase, uridyltransferase, and UDP-glucose 4epirnerase in hornog- consent. enates of frozen liver.
    [Show full text]
  • Disaccharidase Deficiency and Malabsorption of Carbohydrates
    SINGAPORE MEDICAL JOURNAL DISACCHARIDASE DEFICIENCY AND MALABSORPTION OF CARBOHYDRATES C K Lee SYNOPSIS A large proportion of man's caloric intake is carbohydrate and starch and sucrose account for over three-quarters of the total consumed. But the rapid change of the food industry from an art to a high specialised industry in recent years have made available a variety of rare food sugars, amongst which are various disacharides. Since the digestion or enzymic breakdown of carbohydrates is a normal initial requirement that precedes their absorption, and metabolism of carbohydrates varies according to their molecular structure, these rare sugars can cause diseases of carbohydrate intolerance and malabsorption. Intolerance and malabsorption can be due to polysaccharide intolerance because of amylase dy- sfunction (caused by the absence of pancreatic amylases) or malfunctioning of absorptive process (caused by damaged or atrophied absorptive mucosa as a result of another primary disease or a variety of other casautive agents or factors, thus resulting in the Department of Chemistry inability of carbohydrate absorption by the alimentary system). A National University of Singapore third type of intolerance is due to primary deficiency or impaired Kent Ridge activity of digestive disaccharidases of the small intestine. The Singapore 0511 physiological significance and the metabolic consequences of such a lactase, sucrase-isomaltase, mal- C K Lee, Ph.D., F.I.F.S.T., C.Chem. F.R.S.C. deficiency or impaired activity of Senior Lecturer tase and trehalase are discussed. 6 VOLUME 25 NO.1 FEBRUARY 19M INTRODUCTION abundance in the free state. It is a constituent of the important plant and animal reserve sugars, starch and Recent years have seen a considerable advance in all glycogen.
    [Show full text]
  • Congenital Sucrase-Isomaltase Deficiency: What, When, and How?
    October 2020 Volume 16, Issue 10, Supplement 5 Congenital Sucrase-Isomaltase Deficiency: What, When, and How? William D. Chey, MD, AGAF, FACG, FACP Professor of Medicine University of Michigan Health System Ann Arbor, Michigan Brooks Cash, MD Dan and Lille Sterling Professor of Gastroenterology Chief, Division of Gastroenterology, Hepatology, and Nutrition University of Texas Health Science Center at Houston Houston, Texas Anthony Lembo, MD Professor of Medicine Harvard Medical School Boston, Massachusetts Daksesh B. Patel, DO Illinois Gastroenterology Group/GI Alliance Chief, Division of Gastroenterology and Hepatology AMITA St Francis Hospital Evanston, Illinois Accredited by Rehoboth McKinley Christian Health Care Services Kate Scarlata, RDN, LDN Owner, For a Digestive Peace of Mind, LLC Digestive Health Nutrition Consulting Medway, Massachusetts A CME Activity Approved for 1.0 AMA PRA Category 1 CreditTM Provided by the Gi Health Foundation Release Date: October 2020 ON THE WEB: Expiration Date: gastroenterologyandhepatology.net October 31, 2021 Supported by an Estimated time to educational grant from Indexed through the National Library of Medicine complete activity: QOL Medical, LLC (PubMed/Medline), PubMed Central (PMC), and EMBASE 1.0 hour Congenital Sucrase-Isomaltase Deficiency: What, When, and How? To claim 1.0 AMA PRA Category 1 CreditTM for this activity, please visit: gihealthfoundation.org/CSIDMONOGRAPH Target Audience Disclosures This CME monograph will target gastroenterologists, primary care physi- Faculty members are required to inform the audience when they are dis- cians, nurse practitioners, physician assistants, and nurses. cussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned Goal Statement during this educational activity.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Sedative
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Sedative Chemical Dosage (+)-BORNYL-ISOVALERATE -- (-)-DICENTRINE LD50=187 1,8-CINEOLE -- 2-METHYLBUT-3-ENE-2-OL -- 6-GINGEROL -- 6-SHOGAOL -- ACYLSPINOSIN -- ADENOSINE -- AKUAMMIDINE -- ALPHA-PINENE -- ALPHA-TERPINEOL -- AMYL-BUTYRATE -- AMYLASE -- ANEMONIN -- ANGELIC-ACID -- ANGELICIN ED=20-80 ANISATIN 0.03 mg/kg ANNOMONTINE -- APIGENIN 30-100 mg/kg ARECOLINE 1 mg/kg ASARONE -- ASCARIDOLE -- ATHEROSPERMINE -- BAICALIN -- BALDRINAL -- BENZALDEHYDE -- BENZYL-ALCOHOL -- Chemical Dosage BERBERASTINE -- BERBERINE -- BERGENIN -- BETA-AMYRIN-PALMITATE -- BETA-EUDESMOL -- BETA-PHENYLETHANOL -- BETA-RESERCYCLIC-ACID -- BORNEOL -- BORNYL-ACETATE -- BOSWELLIC-ACID 20-55 mg/kg ipr rat BRAHMINOSIDE -- BRAHMOSIDE -- BULBOCAPNINE -- BUTYL-PHTHALIDE -- CAFFEIC-ACID 500 mg CANNABIDIOLIC-ACID -- CANNABINOL ED=200 CARPACIN -- CARVONE -- CARYOPHYLLENE -- CHELIDONINE -- CHIKUSETSUSAPONIN -- CINNAMALDEHYDE -- CITRAL ED 1-32 mg/kg CITRAL 1 mg/kg CITRONELLAL ED=1 mg/kg CITRONELLOL -- 2 Chemical Dosage CODEINE -- COLUBRIN -- COLUBRINOSIDE -- CORYDINE -- CORYNANTHEINE -- COUMARIN -- CRYOGENINE -- CRYPTOCARYALACTONE 250 mg/kg CUMINALDEHYDE -- CUSSONOSIDE-A -- CYCLOSTACHINE-A -- DAIGREMONTIANIN -- DELTA-9-THC 10 mg/orl/man/day DESERPIDINE -- DESMETHOXYANGONIN 200 mg/kg ipr DIAZEPAM 40-200 ug/lg/3-4x/day DICENTRINE LD50=187 DIDROVALTRATUM -- DIHYDROKAWAIN -- DIHYDROMETHYSTICIN 60 mg/kg ipr DIHYDROVALTRATE -- DILLAPIOL ED50=1.57 DIMETHOXYALLYLBENZENE -- DIMETHYLVINYLCARBINOL -- DIPENTENE
    [Show full text]
  • Objectives Anti-Hyperglycemic Therapeutics
    9/22/2015 Some Newer Non-Insulin Therapies for Type 2 Diabetes:Present and future Faculty/presenter disclosure Speaker’s name: Dr. Robert G. Josse SGLT2 Inhibitors Grants/research support: Astra Zeneca, BMS, Boehringer Dopamine D2 Receptor Agonist Ingelheim, Eli Lilly, Janssen, Merck, NovoNordisk, Roche, Bile acid sequestrant sanofi, Consulting Fees: Astra Zeneca, BMS, Eli Lilly, Janssen, Merck, Dr Robert G Josse Division of Endocrinology & Metabolism Speakers bureau: Janssen, Astra Zeneca, BMS, Merck, St. Michael’s Hospital Professor of Medicine Stocks and Shares:None University of Toronto 100-year History of Objectives Anti-hyperglycemic Therapeutics 14 Discuss the mechanism of action of SGLT2 inhibitors, SGLT-2 inhibitor 12 Bromocriptine-QR dopamine D2 receptor agonists and bile acid sequestrants Bile acid sequestrant in the management of type 2 diabetes Number of 10 DPP-4 inhibitor classes of GLP-1 receptor agonist Amylinomimetic anti- 8 Glinide Basal insulin analogue Identify the benefits and risks of the newer non-insulin hyperglycemic Thiazolidinedione agents 6 Alpha-glucosidase inhibitor treatment options Phenformin Human Rapid-acting insulin analogue 4 Sulphonylurea insulin Metformin Intermediate-acting insulin Phenformin Describe the potential uses of these therapies in the 2 withdrawn Soluble insulin treatment of type 2 diabetes 0 1920 1940 1960 1980 2000 2020 Year UGDP, DCCT and UKPDS studies. Buse, JB © 1 9/22/2015 Renal handling of glucose Collecting (180 L/day) Glomerulus duct (1000 mg/L) Proximal =180 g/day Distal tubule S1 tubule Glucose ~90% filtration SGLT2 Inhibitors ~10% S3 Glucose reabsorption Loop No/minimal of Henle glucose excretion S1 segment of proximal tubule S3 segment of proximal tubule - ~90% glucose reabsorbed - ~10% glucose reabsorbed - Facilitated by SGLT2 - Facilitated by SGLT1 SGLT = Sodium-dependent glucose transporter Adapted from: 1.
    [Show full text]
  • Protein-Carbohydrate Interactions Leading to Hydrolysis and Transglycosylation in Plant Glycoside Hydrolase Family 1 Enzymes
    J. Appl. Glycosci., 59, 51‒62 (2012) doi: 10.5458/jag.jag.JAG-2011_022 ©2012 The Japanese Society of Applied Glycoscience Review Protein-carbohydrate Interactions Leading to Hydrolysis and Transglycosylation in Plant Glycoside Hydrolase Family 1 Enzymes (Received December 7, 2011; Accepted January 30, 2012) (J-STAGE Advance Published Date: February 11, 2012) James R. Ketudat Cairns,1,＊ Salila Pengthaisong,1 Sukanya Luang,1 Sompong Sansenya, 1 Anupong Tankrathok1 and Jisnuson Svasti2 1Schools of Biochemistry and Chemistry, Institute of Science, Suranaree University of Technology (Muang District, Nakhon Ratchasima 30000, Thailand) 2Department of Biochemistry and Centre for Protein Structure and Engineering, Faculty of Science, Mahidol University (Phayathai, Bangkok 10400, Thailand) Abstract: Glycoside hydrolase family 1 (GH1) includes enzymes with a wide range of specifi cities in terms of reactions, substrates and products, with plant GH1 enzymes covering a particularly wide range of hy- drolases and transglycosylases. In plants, in addition to β-D-glucosidases, β-D-mannosidases, disacchari- dases, thioglucosidases and hydroxyisourate hydrolase, GH1 has recently been found to include galactosyl and glucosyl transferases that utilize galactolipid and acyl glucose donors, respectively. The amino acids binding to the nonreducing monosaccharide residue of glycosides and oligosaccharides in subsite －1 are largely conserved in GH1 glycoside hydrolases, despite their different glycon specifi cities, and residues outside this subsite contribute to sugar specifi city. The conserved subsite －1 residues form extensive hy- drogen bonding and aromatic stacking interactions to the glycon to distort it toward the transition state, so they must make different interactions with different sugars. Aglycon specifi city is largely determined by interactions with the cleft leading into the active site, but different enzymes appear to interact with their substrates via different residues.
    [Show full text]
  • The Dietary Phytochemical Myricetin Induces Ros-Dependent Breast Cancer Cell Death
    THE DIETARY PHYTOCHEMICAL MYRICETIN INDUCES ROS-DEPENDENT BREAST CANCER CELL DEATH by Allison F. Knickle Submitted in partial fulfilment of the requirements for the degree of Master of Science at Dalhousie University Halifax, Nova Scotia December 2014 © Copyright by Allison F. Knickle, 2014 Table of Contents List of Figures ....................................................................................................... iv List of Tables ........................................................................................................ vi Abstract ................................................................................................................ vii List of Abbreviations and Symbols Used ............................................................. viii Acknowledgements ............................................................................................. xiii CHAPTER 1 INTRODUCTION ............................................................................. 1 1.1. Cancer ...................................................................................................................... 1 1.2 Breast Cancer ........................................................................................................... 1 1.2.1 Triple-negative breast cancer .............................................................................. 3 1.3 Cell death .................................................................................................................. 4 1.3.1 Apoptosis ............................................................................................................
    [Show full text]
  • (Lithocarpus Polystachyus Rehd.) Based Upon Location, Harvesting Time, Leaf Age
    Juan Yang et al., J.Chem.Soc.Pak., Vol. 40, No. 01, 2018 158 Identification and Quantitative Evaluation of Major Sweet Ingredients in Sweet Tea (Lithocarpus polystachyus Rehd.) Based Upon Location, Harvesting Time, Leaf Age Juan Yang, Yuyi Huang, Zhi Yang, Chao Zhou and Xujia Hu* Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, P.R. China. [email protected]* (Received on 11th April 2016, accepted in revised form 13th September 2017) Summary: Lithocarpus polystachyus Rehd. (Sweet Tea) is a traditional sweet tea plant. Flavonoids are the essential sweet active constituents of Sweet Tea, and they have direct relationship with the sweet tonic beverage and traditional herb. In this work, the chemical components of the sweeteners isolated from Sweet Tea were identified as 3-hydroxy phlorizin (1), phlorizin (2), kaempferol-3-O-β-D-glucoside (3) and trilobatin (4) by ESI•-MS and NMR analyses. Quantitative analysis of the flavonoid compounds in Sweet Tea from Yunnan province of China indicated their content was influenced by harvesting time and leaf age. Phlorizin and trilobatin were identified as principal flavonoids in Sweet Tea. The highest concentration of trilobatin was in April, and the highest concentration of phlorizin was in November. The flavonoids content was the highest in young leaves and decreased at mature stage. Moreover, considerable variations of flavonoids content in Sweet Tea from three locations (Yunnan, Hunan, Jiangxi) were observed. It was concluded that the quality of Sweet Tea is greatly influenced by harvesting time, location and leaf age. Therefore, the artificial cultivation of Sweet Tea is necessary to ensure its optimal quality and suitability for specific applications.
    [Show full text]